Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 5,467 | 1,167 | 81 | 190 | 0 |
| Gross Profit | 5,467 | 1,167 | 81 | 190 | N/A |
| Operating Expenses | 20,974 | 12,678 | 6,714 | 6,124 | 0 |
| Operating Income | -15,507 | -11,511 | -6,633 | -5,935 | N/A |
| Interest Expense | 0 | 0 | 21 | 5 | 0 |
| Other Income | 210 | 248 | 66 | 32 | 0 |
| Pre-tax Income | -15,297 | -11,263 | -6,588 | -5,908 | 0 |
| Net Income Continuous | -15,297 | -11,263 | -6,588 | -5,908 | N/A |
| Net Income Discontinuous | N/A | 290 | 1,923 | -57 | N/A |
| Net Income | $-15,297 | $-10,973 | $-4,665 | $-5,965 | $N/A |
| EPS Basic Total Ops | -66.75 | -31.69 | -16.81 | -28.33 | N/A |
| EPS Basic Continuous Ops | -38.64 | -30.73 | -23.53 | -27.85 | N/A |
| EPS Basic Discontinuous Ops | N/A | 0.96 | 6.72 | -0.48 | N/A |
| EPS Diluted Total Ops | -66.75 | -31.69 | -16.81 | -28.33 | N/A |
| EPS Diluted Continuous Ops | -38.64 | -30.73 | -23.53 | -27.85 | N/A |
| EPS Diluted Discontinuous Ops | N/A | 0.96 | 6.72 | -0.48 | N/A |
| EBITDA(a) | $-14,708 | $-10,938 | $-6,049 | $-5,316 | $N/A |